ZITO MARINO, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 1.472
NA - Nord America 1.400
AS - Asia 251
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.133
Nazione #
US - Stati Uniti d'America 1.356
IE - Irlanda 547
IT - Italia 449
SG - Singapore 124
GB - Regno Unito 118
DE - Germania 111
CN - Cina 84
UA - Ucraina 76
CA - Canada 43
GR - Grecia 43
FR - Francia 37
FI - Finlandia 33
TR - Turchia 18
BE - Belgio 14
SE - Svezia 13
KR - Corea 9
MK - Macedonia 6
NL - Olanda 6
PH - Filippine 6
BJ - Benin 5
AT - Austria 4
CH - Svizzera 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
PK - Pakistan 3
BG - Bulgaria 2
ES - Italia 2
MA - Marocco 2
RS - Serbia 2
AU - Australia 1
DK - Danimarca 1
EU - Europa 1
IN - India 1
IR - Iran 1
LT - Lituania 1
MX - Messico 1
TH - Thailandia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.133
Città #
Dublin 543
Santa Clara 319
Chandler 263
Jacksonville 130
Naples 115
Singapore 92
Princeton 66
Roxbury 66
Bremen 45
Medford 37
Elora 36
Munich 36
Beijing 31
Cambridge 29
New York 29
Caserta 25
Des Moines 23
Aversa 20
Ercolano 18
Napoli 18
Wilmington 18
Brussels 14
Boardman 13
Grumo Nevano 11
Woodbridge 10
Lappeenranta 8
Seoul 8
Helsinki 7
Los Angeles 7
Portici 7
Seattle 7
Ann Arbor 6
Düsseldorf 6
Ariano Irpino 5
Ashburn 5
Falls Church 5
Nanchang 5
Rome 5
San Giuliano 5
Volla 5
Boydton 4
Lausanne 4
Norwalk 4
Ottawa 4
San Mateo 4
Tianjin 4
Berlin 3
Brno 3
Casaluce 3
Castellammare di Stabia 3
Castello di Brianza 3
Clifton 3
Houston 3
Istanbul 3
Maynooth 3
Menlo Park 3
Mountain View 3
Potenza 3
San Giorgio a Cremano 3
Vienna 3
Amsterdam 2
Atlanta 2
Casalnuovo di Napoli 2
Cava De' Tirreni 2
Como 2
Frankfurt am Main 2
Fremont 2
Giugliano in Campania 2
Haikou 2
Hangzhou 2
Hong Kong 2
Manassas 2
Mercato San Severino 2
Nanjing 2
Oristano 2
Pagani 2
Paris 2
Redwood City 2
Salerno 2
Segrate 2
Shanghai 2
Shenyang 2
Silandro 2
Sofia 2
Toronto 2
Torre Del Greco 2
Tortona 2
Trieste 2
Zhengzhou 2
Adnan Menderes 1
Afragola 1
Angeles City 1
Arienzo 1
Auburn Hills 1
Avellino 1
Belgrade 1
Calvizzano 1
Central 1
Cercola 1
Changsha 1
Totale 2.233
Nome #
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 86
Predictive biomarkers along gastric cancer pathogenetic pathways 83
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 68
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 67
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 65
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 60
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 59
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 58
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 58
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 55
A new look at the ALK gene in cancer: copy number gain and amplification 55
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 55
GOLPH3 promotes oncogenesis by controlling the intra-Golgi trafficking of glycosphingolipid synthases 55
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 54
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 53
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 51
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 51
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 51
Cytologic diagnosis of metastatic melanoma by FNA: A practical review 51
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 50
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 48
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 48
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 48
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 48
New therapeutic perspectives in CCDC6 deficient lung cancer cells 47
Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies 47
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples 47
Interventional cytopathology in COVID-19 ERA 46
null 45
Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma 44
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 43
Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients 43
CRISPR-barcoding in non small cell lung cancer: From intratumor genetic heterogeneity modeling to cancer therapy application 43
Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features 43
HER2 EXPRESSION IN GASTROINTESTINAL TUMOR. A FOCUS ON DIAGNOSTIC ALGORITHM OF HER2. STATUS FROM GASTRIC TO INTESTINAL CANCER 43
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 43
Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features 42
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 42
Immunohistochemistry for cancer stem cells detection: Principles and methods 40
null 40
Diagnostic accuracy of FNA cytology for diagnosis of salivary gland tumors in pediatric patients 39
Mitochondrial AKAP1 supports mTOR pathway and tumor growth 39
MALT GASTRIC LYMPHOMA: AN UPDATE OF PATHOGENETIC FEATURES 39
Concomitant ALK/KRAS and ALK/EGFR mutations in non small cell lung cancer: Different profile of response to target therapies 36
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond 36
Second Diagnostic Opinion by Experienced Dermatopathologists in the Setting of a Referral Regional Melanoma Unit Significantly Improves the Clinical Management of Patients With Cutaneous Melanoma 35
Correction: Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 35
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 34
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV 34
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 33
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas 33
Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features 33
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 33
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 32
AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma 32
Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks 31
To Get the Most out of the Least: BRAF Molecular Evaluation in Melanoma Metastases on Cell Suspension from Fine Needle Aspiration Cytology Needle Rinses 30
Mesenchymal neoplasms: Is it time for cytology? New perspectives for the pre-operative diagnosis of soft tissue tumors in the molecular era 30
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 29
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy 28
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 27
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC 27
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis 27
How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls 26
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 26
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era 26
The GOLPH3 oncogene controls the intra-Golgi recycling of sphingolipid glycosylating enzymes to promote proliferation 26
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer 25
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers 24
AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma 23
Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy 23
A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS-The Experience in Pathological Anatomy Unit 23
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 22
RNAScope in situ Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor 21
Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors 20
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multi-institutional research study 20
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 19
NTRK Gene Fusion Detection in Atypical Spitz Tumors 19
Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods 17
Detection of ROSI rearrangement in non-small cell lung cancer: Current and future perspectives 16
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems 15
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS 14
Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method 14
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors 13
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 10
COVID-19: detection methods in post-mortem samples 10
The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules 10
The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 9
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 9
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 9
Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples 7
Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma 4
Totale 3.327
Categoria #
all - tutte 19.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 0 0 34 11 4 9 15 3
2020/2021276 12 0 17 13 33 12 39 23 18 54 48 7
2021/2022478 5 12 3 4 121 7 30 10 21 48 75 142
2022/20231.085 126 36 20 87 98 80 11 52 519 14 18 24
2023/2024495 44 27 25 33 143 39 20 17 12 11 42 82
2024/2025626 24 19 12 37 298 236 0 0 0 0 0 0
Totale 3.327